Reuters logo
in 7 months
BRIEF-Arena Pharmaceuticals completes enrollment in phase 2 clinical trial for PAH
December 7, 2016 / 1:45 PM / in 7 months

BRIEF-Arena Pharmaceuticals completes enrollment in phase 2 clinical trial for PAH

1 Min Read

Dec 7 (Reuters) - Arena Pharmaceuticals Inc :

* Arena Pharmaceuticals - look forward to seeing results from Phase 2 trial mid-year

* Arena Pharmaceuticals Inc - study enrolled approximately 60 patients at sites globally

* Arena Pharmaceuticals completes enrollment in ralinepag phase 2 clinical trial for pulmonary arterial hypertension (PAH) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below